NP Thyroid 120 — Class I drug recall D-0036-2021
Terminated recall by Acella Pharmaceuticals, LLC, reported 2020-10-28, distributed nationwide. Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4)
| Recall number | D-0036-2021 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Acella Pharmaceuticals, LLC, Alpharetta, GA, United States |
| Recall initiated | 2020-09-17 |
| Classified | 2020-10-19 |
| Reported by FDA | 2020-10-28 |
| Terminated | 2022-12-08 |
| Distributed | Nationwide (US) |
| Quantity | 9,816 bottles |
| Reason classes | labeling, potency |
| NDC | 42192-0327, 42192-0327-01, 42192-0327-30, 42192-0327-90, 42192-0328, 42192-0328-01, 42192-0328-30, 42192-0328-90, 42192-0329, 42192-0329-01, 42192-0329-10, 42192-0329-30, 42192-0329-90, 42192-0330, 42192-0330-01, 42192-0330-10, 42192-0330-30, 42192-0330-90, 42192-0331, 42192-0331-01, 42192-0331-10, 42192-0331-30, 42192-0331-90 |
| Lot numbers | M328F19-3 |
| Expiration dates | 2020-11 |
Product
NP Thyroid 120, Thyroid Tablets, USP 2 grain (120 mg) 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-328-01
Reason for recall
Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0036-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.